Nuria Raguer

Nuria Raguer

Auto-generated profile, based on publicly available information

Nuria Raguer

Department of Neurophysiology, Hospital Universitari Vall d'Hebron (HUVH), Barcelona, Spain

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2000 in Neurology
Verified
Journal Article
Closed access
PDF file
SPS. Pedraza
S. Pedraza
JGJ. GámEz
J. GámEz
ARA. Rovira
A. Rovira
AZA. Zamora
A. Zamora
EGE. Grive
E. Grive
JRJ. Ruscalleda
J. Ruscalleda
Article abstract The authors studied the MRI findings of three patients with Möbius syndrome. Möbius syndrome is a rare congenital disorder characterized by complete or partial facial diplegia accompanied by other cranial nerve palsies. MRI demonstrated brainstem hypoplasia with straightening of the fourth ventricle floor, indicating an absence of the facial colliculus. These MRI features suggest the diagnosis of Möbius syndrome and correlate with the clinical and neurophysiologic findings.

1 August 2006 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
JGJosep Gamez
Josep Gamez
MCMarc Corbera-Bellalta
Marc Corbera-Bellalta
Gisela Nogales-GadeaGisela Nogales-Gadea
Gisela Nogales-Gadea
NRNuria Raguer
Nuria Raguer
EGElena García-Arumí
Elena García-Arumí
JSJosé Alvarez Sabín
José Alvarez Sabín

1 November 1993 in Kidney International
Verified
Journal Article
Closed access
TSTeresa Sagalés
Teresa Sagalés
VGVictor Gimeno
Victor Gimeno
MPM. Jesus Planella
M. Jesus Planella
NRNuria Raguer
Nuria Raguer
JBJorge Bartolome
Jorge Bartolome

7 July 2017 in Brain and Behavior
Verified
Journal Article
Open access
PDF file
OFOriol de Fabregues
Oriol de Fabregues
JDJoan Dot
Joan Dot
MAMonder Abu-Suboh
Monder Abu-Suboh
JHJorge Hernández-Vara
Jorge Hernández-Vara
AFAlex Ferré
Alex Ferré
JSJosé Alvarez Sabín
José Alvarez Sabín
Introduction: Levodopa‐carbidopa intestinal gel (LCIG) infusion has demonstrated to improve motor fluctuations. The aim of this study is to assess the long‐term safety and effectiveness of LCIG infusion in advanced Parkinson's disease (PD) patients with motor fluctuations and its effect in nonmotor symptoms.Methods: Adverse events (AE) and their management, clinical motor, and nonmotor aspects were assessed up to 10 years. Thirty‐seven patients were treated with LGIC; in three subsets of patients, specific batteries of tests were used to assess cognitive and behavior assessment for 6 months, quality of sleep for 6 months, and quality of life and caregiver burden for 1 year.Results: There was a high number of AE, but manageable, most of mild and moderate severity. All patients experienced significant improvement in motor fluctuations with a reduction in mean daily off time of 4.87 hr after 3 months (n = 37) to 6.25 hr after 9 years (n = 2). Diskynesias remained stables in 28 patients (75.7%) and improved in 5 patients (13.5%). There was no neuropsychological deterioration, but an improvement in attentional functions, voluntary motor control, and semantic fluency. Quality of sleep did not worsen, and there was an improvement in the subjective parameters, although overnight polysomnography did not change. There was a significant sustained improvement of 37% in PD‐Q39 after 3 months and to 1 year, and a significant reduction in caregiver burden of 10% after 3 months.Conclusion: LCIG infusion is a safe and efficacious treatment for the control of motor fluctuations, and for improvement or nonworsening of nonmotor aspects, long‐term sustained, and feasible for use in routine care.

1 February 2017 in Pediatric Critical Care Medicine
Verified
Journal Article
Closed access
LGLaura Gil-Juanmiquel
Laura Gil-Juanmiquel
MGMargarida Gratacós
Margarida Gratacós
YCYolanda Castilla-Fernández
Yolanda Castilla-Fernández
JPJoaquim Piqueras
Joaquim Piqueras
TBTracy Baust
Tracy Baust
Joan Sanchez-de-ToledoJoan Sanchez-de-Toledo
Joan Sanchez-de-Toledo
Objective: To assess the utility of bedside ultrasound combining B- and M-mode in the diagnosis of abnormal diaphragmatic motion in children after heart surgery.Design: Prospective post hoc blinded comparison of ultrasound performed by two different intensivists and fluoroscopy results with electromyography.Setting: Tertiary university hospital.Subjects: Children with suspected abnormal diaphragmatic motion after heart surgery.Interventions: None.Measurements and Main Results: Abnormal diaphragmatic motion was suspected in 26 children. Electromyography confirmed the diagnosis in 20 of 24 children (83.3%). The overall occurrence rate of abnormal diaphragmatic motion during the study period was 7.5%. Median patient age was 5 months (range, 16 d to 14 yr). Sensitivity and specificity of chest ultrasound performed at the bedside by the two intensivists (91% and 92% and 92% and 95%, respectively) were higher than those obtained by fluoroscopy (87% and 83%). Interobserver agreement (k) between both intensivists was 0.957 (95% CI, 0.87–100).Conclusions: Chest ultrasound performed by intensivists is a valid tool for the diagnosis of diaphragmatic paralysis, presenting greater sensitivity and specificity than fluoroscopy. Chest ultrasound should be routinely used after pediatric heart surgery given its reliability, reproducibility, availability, and safety.

13 August 2002 in Neurology
Verified
Journal Article
Closed access
PDF file
JGJ. Gamez
J. Gamez
CFC. Ferreiro
C. Ferreiro
MAM. L. Accarino
M. L. Accarino
LGL. Guarner
L. Guarner
STS. Tadesse
S. Tadesse
MHM. Hirano
M. Hirano
Clinical, biochemical, and genetic features of a Spanish family with mitochondrial neurogastrointestinal encephalomyopathy are reported. The proband presented with severe gastrointestinal dysmotility and the affected sister had extraocular muscle weakness. In both affected individuals, biochemical defects of thymidine phosphorylase and a pathogenic G-to-A transition mutation at nucleotide 435 in the thymidine phosphorylase gene were identified. The first thymidine phosphorylase mutation identified in Spain showed phenotypic variability at onset.